The DOI matches its Crossref record; 39 of the 40 references it cites were found in a registry or an index.
Activity-based protein profiling reveals off-target proteins of the FAAH inhibitor BIA 10-2474
Open accessAbstract
A clue to a drug's neurotoxicity?: The drug BIA 10-2474 inhibits fatty acid amide hydrolase (FAAH), a lipase that degrades a specific endocannabinoid. On the basis of this activity, BIA 10-2474 was being developed as a potential treatment for anxiety and pain. In a phase 1 trial of the drug, one subject died, and four others suffered brain damage. As an initial step in investigating whether inhibition of off-target proteins by BIA 10-2474 might contribute to its clinical neurotoxicity, van Esbroeck et al. used activity-based proteomic assays to identify proteins targeted by the drug. Studying human cells and brain samples from subjects not associated with the trial, they found that BIA 10-2474 targeted several different lipases in addition to FAAH. It also substantially altered lipid metabolism in cultured neurons. Science , this issue p. 1084
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“During the period of its suspension, it was revealed that these problems were due to off-target effects of this agent that led to alterations in lipid networks in the cortexeffects which were not observed in more specific FAAH inhibitors (van Esbroeck et al., 2017).”
From Novel pharmacological targets in drug development for the treatment of anxiety and anxiety-related disorders (2019) · cites this paper as van Esbroeck et al., 2017
Experimental — accuracy not yet measuredIn the citing paper
“In light of the death and adverse events in other subjects given repeated high doses of the FAAH inhibitor BIA-102474-101 in a clinical trial (Kerbrat et al, 2016), it is crucial to note that this drug has multitude of off-targets, including inhibition of essential blood-clotting factors thrombin and Factor VII (van Esbroeck et al, 2017;Molinski et al, 2017), which may contributed to its toxicity.”
From The endogenous cannabinoid system: a budding source of targets for treating inflammatory and neuropathic pain (2018) · cites this paper as van Esbroeck et al, 2017
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor
Devane, W. A., Hanuš, L., Breuer, A., Pertwee, R. G., Stevenson, L. A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A., & Mechoulam, R. (1992) · Science · doi:10.1126/science.1470919 · Cited by 5,633
Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides
Cravatt, B. F., Giang, D. K., Mayfield, S. P., Boger, D. L., Lerner, R. A., & Gilula, N. B. (1996) · Nature · doi:10.1038/384083a0 · Cited by 2,125
Self-citationModulation of anxiety through blockade of anandamide hydrolysis
Kathuria, S., Gaetani, S., Fegley, D., Valiño, F., Duranti, A., Tontini, A., Mor, M., Tarzia, G., Rana, G. L., Calignano, A., et al. (2003) · Nature Medicine · doi:10.1038/nm803 · Cited by 1,293
Activity-based protein profiling: The serine hydrolases
Liu, Y., Patricelli, M. P., & Cravatt, B. F. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.26.14694 · Cited by 1,143
Self-citationLong, J. Z., Nomura, D. K., Vann, R. E., Walentiny, D. M., Booker, L., Jin, X., Burston, J. J., Sim‐Selley, L. J., Lichtman, A. H., Wiley, J. L., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0909411106 · Cited by 405
Self-citationHuggins, J. P., Smart, T. S., Langman, S., Taylor, L., & Young, T. (2012) · Pain · doi:10.1016/j.pain.2012.04.020 · Cited by 375
Enzyme Inhibitor Discovery by Activity-Based Protein Profiling
Niphakis, M. J., & Cravatt, B. F. (2014) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-060713-035708 · Cited by 374
Self-citationA road map to evaluate the proteome-wide selectivity of covalent kinase inhibitors
Lanning, B. R., Whitby, L. R., Dix, M. M., Douhan, J., Gilbert, A. M., Hett, E. C., Johnson, T., Joslyn, C. M., Kath, J. C., Niessen, S., et al. (2014) · Nature Chemical Biology · doi:10.1038/nchembio.1582 · Cited by 356
Self-citationBachovchin, D. A., Ji, T., Li, W., Simon, G. M., Blankman, J. L., Adibekian, A., Hoover, H. S., Niessen, S., & Cravatt, B. F. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1011663107 · Cited by 274
Self-citationAnandamide acts as an intracellular messenger amplifying Ca2+ influx via TRPV1 channels
van der Stelt, M., Trevisani, M., Vellani, V., PETROCELLIS, L. D., Moriello, A. S., Campi, B., McNaughton, P. A., Geppetti, P., & Marzo, V. D. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600784 · Cited by 243
Research works printed but not linked: 1
- A. Patat presentation at the Safety and Regulation in Early Clinical Drug Development Symposium Ghent Belgium 2 December 2016.
Cited by
Sorted by citations
Items 301–344 of 344
Research and discovery: Essential partners but just a start
Miller, S. M., Moos, W. H., Munk, B. H., Munk, S. A., Hart, C. P., & Spellmeyer, D. C. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-824304-6.00011-0
Miller, S. M., Moos, W. H., Munk, B. H., Munk, S. A., Hart, C. P., & Spellmeyer, D. C. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-824304-6.00010-9
Alexander, S. P. H., Doherty, P., Fairlie, D. P., Fowler, C. J., Overall, C. M., Rawlings, N. D., Southan, C., & Turner, A. J. (2023) · IUPHAR/BPS Guide to Pharmacology CITE · doi:10.2218/gtopdb/f799/2023.1
Endocannabinoid turnover in GtoPdb v.2023.1
Alexander, S. P. H., Doherty, P., Fowler, C. J., Gertsch, J., & van der Stelt, M. (2023) · IUPHAR/BPS Guide to Pharmacology CITE · doi:10.2218/gtopdb/f943/2023.1
Conole, D., Cao, F., Ende, C. W. A., Xue, L., Kantesaria, S., Kang, D., Jin, J. H., Owen, D. R., Lohr, L., Schenone, M., et al. (2023) · Angewandte Chemie · doi:10.1002/ange.202311190
Kovacs, D., Flori, E., Bastonini, E., Mosca, S., Migliano, E., Cota, C., Zaccarini, M., Briganti, S., & Cardinali, G. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242417379
Pollak, U., Aran, A. A., Binshtok, A. M., Bar‐Yosef, O., Bronicki, R. A., Checchia, P. A., & Finkelstein, Y. (2024) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000001560
Author response: Human adherent cortical organoids in a multi-well format
van der Kroeg, M., Bansal, S., Unkel, M., Smeenk, H., Kushner, S. A., & de Vrij, F. M. S. (2024) · eLife · doi:10.7554/elife.98340.1.sa4
Self-citationeLife Assessment: Human adherent cortical organoids in a multi-well format
Konopka, G. (2024) · eLife · doi:10.7554/elife.98340.1.sa3
Human adherent cortical organoids in a multi-well formatPreprint
van der Kroeg, M., Bansal, S., Unkel, M., Smeenk, H., Kushner, S. A., & de Vrij, F. M. S. (2024) · eLife · doi:10.7554/elife.98340 · Cited by 1
Self-citationAnandamide: The good and bad in epilepsy
Gom, R. C., Wickramarachchi, P., Colangeli, R., & Teskey, G. C. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-19081-0.00018-4
Rock, E. M., & Parker, L. A. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-19081-0.00005-6
Mass Spectrometry-Based Methods in CNS Drug Discovery
Blasco, G., Schreiber, R., & van Kruining, D. (2024) · Springer eBooks · doi:10.1007/978-3-031-61992-2_6
Rock, E. M., & Parker, L. A. (2024) · Current topics in behavioral neurosciences · doi:10.1007/7854_2024_554
Chemoproteomics Approaches for Diverse Modalities
Eberl, H. C., Knecht, S., Queisser, M. A., & Bantscheff, M. (2025) · Wiley eBooks · doi:10.1002/9781394236145.ch19
Chen, S., Sanner, M. F., Leone, D.-L. G., Loroch, S., Forli, S., & Verhelst, S. H. L. (2025) · Analytical Chemistry · doi:10.1021/acs.analchem.5c02409
Endocannabinoids in pain modulation
Chapman, V., & Woodhams, S. G. (2025) · Handbook of behavioral neuroscience · doi:10.1016/b978-0-443-13908-6.00010-4
Nogueira, D. D. S. (2019) · theses.fr (ABES) · doi:10.70675/d429d5dbz5001z4e60z9622z4f636e667f17
4-Oxo-2-Nonenal Crosslinks Vicinal Cysteine-Lysine Pairs in Cellular Proteins
Cheng, R., Wang, M., Liu, K., Fu, L., Xu, P., Tian, C., & Yang, J. H. (2026) · Molecular & Cellular Proteomics · doi:10.1016/j.mcpro.2026.101573
Serra, I., Bisconti, E., Vergara, D., Giudetti, A. M., & Vari, F. (2026) · British Journal of Pharmacology · doi:10.1111/bph.70511
Bagher, A. M. (2026) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2026.179130
Feng, J., Zheng, X., Zhu, F., Gan, Z., Liu, Z., He, J., & Dai, Y. (2026) · Clinical Immunology · doi:10.1016/j.clim.2026.110759
Wang, S., Tavassoly, O., Chowdhury, M. A., Carter, L., Brown, D., Bravo, R. C., Madaan, A., Zhang, Z., Tesolin, D., Quartey, M. O., et al. (2026) · Cell chemical biology · doi:10.1016/j.chembiol.2026.07.007
Endogenous Lipid Signals in Energy Homeostasis and Fibrosis
Meo, C. D., Palaniappan, S., Urbano, C., Cimino, G., Cestra, F., Dominicis, N. D., Carnicelli, V., Tisi, A., & Maccarrone, M. (2026) · Biomolecules · doi:10.3390/biom16081170
Self-citationCatalano, A. A., Fezza, F., Duranti, A., Cavalluzzi, M. M., Lentini, G., Mangiatordi, G. F., Rocchi, M., & Maccarrone, M. (2026) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2026.2716127
Self-citationBrake, F. H. G. T., Gagestein, B., van der Stelt, M., & Janssen, A. P. A. (2026) · ACS Chemical Biology · doi:10.1021/acschembio.6c00557
Self-citationMicrobiome‐Endocannabinoidome Crosstalk as an Immunometabolic Rheostat in Inflammatory Disease
Maghembe, R. S., Damian, D., Bahati, S. Y., & Makaranga, A. (2026) · FASEB BioAdvances · doi:10.1096/fba.2026-00201
Cui, Y., Wang, Y., Wang, X., Fei, C., Wang, C., Ma, Z., Ye, W., Zhou, W., Zhou, D., Guo, Z., et al. (2026) · Journal of Proteomics · doi:10.1016/j.jprot.2026.105753
BindingDB (2024) · UC San Diego · doi:10.7270/q2st7v2x
BindingDB Entry 50018469: Activity-based protein profiling: Recent advances in medicinal chemistry.
BindingDB (2024) · UC San Diego · doi:10.7270/q23b64bd
BindingDB Entry 50006982: N-Acyl pyrazoles: Effective and tunable inhibitors of serine hydrolases.
BindingDB (2021) · UC San Diego · doi:10.7270/q2rx9gcw
BindingDB Entry 50019172: Development of
BindingDB (2024) · UC San Diego · doi:10.7270/q2x92gn5
Metadata
- Authors
- van Esbroeck, A. C. M., Janssen, A. P. A., Cognetta, A. B., Ogasawara, D., Shpak, G., van der Kroeg, M., Kantae, V., Baggelaar, M. P., de Vrij, F. M. S., Deng, H., Allarà, M., Fezza, F., Lin, Z., van der Wel, T., Soethoudt, M., Mock, E. D., den Dulk, H., Baak, I. L., Florea, B. I., Hendriks, G., De Petrocellis, L., Overkleeft, H. S., Hankemeier, T., De Zeeuw, C. I., Di Marzo, V., Maccarrone, M., Cravatt, B. F., Kushner, S. A., & van der Stelt, M.
- Affiliations
- Department of Molecular Physiology, Leiden Institute of Chemistry, Leiden University, Einsteinweg 55, 2333 CC, Leiden, Netherlands.
- Leiden University (NL)
- Scripps Research Institute (US)
- Erasmus MC (NL)
- Department of Psychiatry, Erasmus University Medical Centre, 3000 CA, Rotterdam, Netherlands.
- Istituto di Chimica Biomolecolare (IT)
- University of Rome Tor Vergata (IT)
- Toxys B.V., Robert Boyleweg 4, 2333 CG, Leiden, Netherlands.
- Endocannabinoid Research Group, Institute of Biomolecular Chemistry, Consiglio Nazionale delle Ricerche (CNR), Via Campi Flegrei 34, Comprensorio Olivetti, 80078 Pozzuoli, Italy.
- Department of Neuroscience, Erasmus Medical Centre, 3000 CA, Rotterdam, Netherlands.
- Università Campus Bio-Medico (IT)
- Corresponding author
- Janssen, Antonius P. A.
- Cognetta, Armand B.
- Ogasawara, Daisuke
- Kushner, Steven A.
- ORCID
- van Esbroeck, Annelot C. M.
- Janssen, Antonius P. A.
- Cognetta, Armand B.
- Ogasawara, Daisuke
- Shpak, Guy
- van der Kroeg, Mark
- Kantae, Vasudev
- Baggelaar, Marc P.
- Deng, Hui
- Allarà, Marco
- Fezza, Filomena
- Lin, Zhanmin
- van der Wel, Tom
- Soethoudt, Marjolein
- Mock, Elliot D.
- den Dulk, Hans
- Baak, Ilse L.
- Florea, Bogdan I.
- Hendriks, Giel
- De Petrocellis, Luciano
- Overkleeft, Herman S.
- Hankemeier, Thomas
- Di Marzo, Vincenzo
- Maccarrone, Mauro
- Cravatt, Benjamin F.
- Kushner, Steven A.
- van der Stelt, Mario
- Venue
- Science
- Published
- 2017-06-09
- Volume
- 356
- Issue
- 6342
- Pages
- 1084-1087
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC5641481
- OpenAlex
- W2621737540
- Cited by
- 332
- References
- 40
- Citations by year
- 2026: 23 · 2025: 20 · 2024: 33 · 2023: 25 · 2022: 27 · 2021: 33 · 2020: 63 · 2019: 50 · 2018: 47 · 2017: 10
- FWCI
- 32.45
- Type
- journal article
- Language
- en
- Open access
- green
- pure.eur.nl
- Licence
- other-oa
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (publishedVersion, other-oa)
- KNAW Research Portal (The Royal Netherlands Academy of Arts and Sciences) (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Leiden Repository (Leiden University) (submittedVersion, other-oa)
- Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion, other-oa)
- RePub (Erasmus University Rotterdam) (submittedVersion, other-oa)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Cineca Institutional Research Information System (Tor Vergata University) (submittedVersion)
- Leiden Repository (Leiden University) (submittedVersion)
- RePub (Erasmus University Rotterdam) (submittedVersion)
- Archivio Istituzionale della Ricerca - Università degli Studi dell Aquila (submittedVersion)
- Funders
- National Institutes of Health (award304469, DA033760)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- FAAH inhibitors, off-target effects, lipase inhibition, neurotoxicity, activity-based protein profiling, fatty acid amide hydrolase, lipid metabolism, cortical neurons, drug safety
- MeSH terms
- Fatty Acid Amide Hydrolases, Amidohydrolases, Analgesics, Cross Reactions, Cyclic N-Oxides, Humans, Neurons, Pyridazines, Pyridines, Anti-Anxiety Agents, Urea, Clinical Trials, Phase I as Topic, Cell Line, Tumor, Protein Interaction Maps
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
